Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

65.08 +2.46 (+3.92%)
Streaming Delayed Price Updated: 2:31 PM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,353,515
Open 65.26
Bid (Size) 65.07 (3)
Ask (Size) 65.08 (4)
Prev. Close 62.62
Today's Range 64.16 - 65.41
52wk Range 57.00 - 148.15
Shares Outstanding N/A
Dividend Yield 3.38%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy. 
Via Benzinga
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators
Patients will be able to access Novo Nordisk’s direct-to-patient online pharmacy, NovoCare, through the telehealth providers. 
Via Stocktwits
Exposures Product Safety

Performance

YTD
-25.6%
-25.6%
1 Month
-6.3%
-6.3%
3 Month
-25.6%
-25.6%
6 Month
-42.1%
-42.1%
1 Year
-48.7%
-48.7%

More News

Read More
Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy
Via Investor's Business Daily
Exposures Product Safety
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
Via Stocktwits
Exposures Product Safety
Pfizer Stock Climbs Pre-Market On Bladder Cancer Trial Success: Retail Digests Data Ahead Of Q1 Print
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property
Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
Via Benzinga
Exposures Product Safety
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Via Stocktwits
Topics Lawsuit
Exposures Financial Legal Product Safety
Why Novo Nordisk Stock Dropped Today
Via The Motley Fool
Top 2 Health Care Stocks That May Crash This Month
Via Benzinga
Viking Therapeutics Stock May Struggle After As-Expected Report
Via MarketBeat
The Best Stock to Buy With Less Than $60 in the Market Sell-Off
Via The Motley Fool
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
Exposures Political
Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
Via MarketBeat
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
Via The Motley Fool
Is Eli Lilly Stock a Buy?
Via The Motley Fool
Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence
Via Benzinga
Why Novo Nordisk Stock Popped Today
Via The Motley Fool
Exposures Product Safety
Novo Nordisk Just Leapfrogged Eli Lilly With A Weight-Loss Pill; Shares Pop
Via Investor's Business Daily
Exposures Product Safety
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.
Via The Motley Fool
Down 60%, Is This Growth Stock Too Cheap to Ignore?
Via The Motley Fool
Novo Nordisk's FDA Submission For Obesity Pill Gets Retail Traders Buzzing Amid Fierce Eli Lilly Rivalry
Via Stocktwits
Exposures Product Safety
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
Via The Motley Fool
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Via The Motley Fool
Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 65.08
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/29/25 02:31 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.